5942-8 |
Coagulation reptilase induced |
Time |
PPP^Control |
Pt |
Qn |
Coag |
|
ACTIVE |
Reptilase time in Control Platelet poor plasma by Coagulation assay |
|
MIN |
DefinitionDescription |
|
|
s |
|
|
|
|
|
|
COAG |
|
5942-8 |
|
Coag |
|
|
Observation |
|
|
|
0 |
Reptilase time Cont PPP |
|
|
|
Y |
|
Atroxin time; Clot; Clottable; Coag; Coagulation assay; Contrl; Hematology; Heme; Normal; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Reptilase time; Tilt tube |
2.73 |
1.0d |
|
|
|
|
|
|
|
s |
|
|
|
0 |
59420-0 |
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA |
PrThr |
Cvx |
Pt |
Ord |
Probe.amp.sig |
|
ACTIVE |
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by Probe with signal amplification |
|
MIN |
DefinitionDescription |
|
|
|
Detected Not Detected |
|
|
|
|
|
MICRO |
|
59420-0 |
|
Probe.amp.sig |
|
|
Both |
|
|
|
0 |
HPV I/H Risk 4 DNA Cvx Ql Probe+sig amp |
|
|
|
N |
|
Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Cervix; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; Gyn; Gynecology; HC; HPA; HPV; HPV I/H Risk 4; HPV16; HPV16 and 18; HPV16+18; HPV16+18+H Risk 12; HPV16+18+HRisk12DNA; Human papillomavirus; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Papilloma virus high risk; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen |
2.73 |
2.32 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
59421-8 |
Neisseria meningitidis serogroups A+B+C+w135+Y Ag |
PrThr |
CSF |
Pt |
Ord |
LA |
|
ACTIVE |
Neisseria meningitidis serogroups A+B+C+w135+Y Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
59421-8 |
|
LA |
|
|
Both |
|
|
|
0 |
N men sg A+B+C+W135+Y Ag CSF Ql LA |
|
|
|
N |
|
A,B; Antigen; Antigens; Cerebral spinal fluid; Cerebrospinal Fl; ID; Infectious Disease; InfectiousDisease; LAT; Latex agglutination; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; N men; N men sg A+B+C+W135+Y; N menigitidis; N meningitidis; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.64 |
2.32 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 'serogroups'added to the Component for clarification. |
0 |
59422-6 |
Leptospira interrogans serovar Javanica Ab |
Titr |
Ser |
Pt |
SemiQn |
Aggl |
|
ACTIVE |
Leptospira interrogans sv Javanica Ab [Titer] in Serum by Agglutination |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
59422-6 |
|
Aggl |
|
|
Both |
|
|
|
0 |
L inter Javani Ab Titr Ser Aggl |
|
|
|
N |
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L inter; L inter Javani; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.32 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
59423-4 |
Influenza virus A hemagglutinin type RNA |
ID |
XXX |
Pt |
Nom |
Probe.amp.tar |
|
ACTIVE |
Influenza virus A hemagglutinin type RNA [Identifier] in Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
59423-4 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
FLUAV HA RNA Spec NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV HA; FLUV; Fowl plague; HA; ID; Ident; Identifier; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.69 |
2.32 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59424-2 |
Influenza virus A hemagglutinin type RNA |
ID |
Isolate |
Pt |
Nom |
Probe.amp.tar |
|
ACTIVE |
Influenza virus A hemagglutinin type RNA [Identifier] in Isolate by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
59424-2 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
FLUAV HA RNA Islt NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV HA; FLUV; Fowl plague; HA; ID; Ident; Identifier; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.63 |
2.32 |
|
|
|
|
|
|
|
|
|
|
|
0 |
5943-6 |
Coagulation reptilase induced |
Time |
PPP^Control |
Pt |
Qn |
Tilt tube |
|
DEPRECATED |
Deprecated Reptilase time in Platelet poor plasma from control by Coagulation assay |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
COAG |
|
5943-6 |
|
Tilt tube |
|
|
|
|
|
|
0 |
Deprecated Reptilase PPP Cont Qn |
|
|
|
|
|
Atroxin time; Coag; Contrl; Hematology; Heme; Normal; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Reptilase time |
2.36 |
1.0d |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
5944-4 |
Coagulation Russell viper venom induced |
Time |
PPP^Control |
Pt |
Qn |
Tilt tube |
|
DEPRECATED |
Deprecated Russell viper venom time in Platelet poor plasma from control by Coagulation assay |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
COAG |
|
5944-4 |
|
Tilt tube |
|
|
|
|
|
|
0 |
Deprecated Coag RVV Ind PPP Cont Qn |
|
|
|
|
|
Coag; Contrl; Hematology; Heme; Normal; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Rus; Russell viper venom time; RVV; RVV time; Stypven time |
2.36 |
1.0d |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
5945-1 |
Coagulation Russell viper venom induced |
Time |
PPP |
Pt |
Qn |
Tilt tube |
|
DEPRECATED |
Deprecated Russell viper venom time in Platelet poor plasma by Coagulation assay |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
COAG |
|
5945-1 |
|
Tilt tube |
|
|
|
|
|
|
0 |
Deprecated Coag RVV Ind PPP Qn |
|
|
|
|
|
Coag; Hematology; Heme; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Rus; Russell viper venom time; RVV; RVV time; Stypven time |
2.36 |
1.0d |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
59453-1 |
Morse Fall Scale panel |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Morse Fall Scale panel |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.MFS |
|
59453-1 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; MFS; Morse Fall Score; Ordinal; Pan; PANEL.SURVEY.MFS; Panl; Pnl; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MFS |
2.32 |
2.32 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
59454-9 |
History of falling; immediate or within 3Mo |
Find |
^Patient |
Pt |
Ord |
Morse Fall Scale |
|
ACTIVE |
History of falling; immediate or within 3 months [Morse Fall Scale] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MFS |
|
59454-9 |
|
Morse Fall Scale |
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; H/O; Hx; MFS; Morse Fall Score; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MFS |
2.44 |
2.32 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59455-6 |
Secondary diagnosis is present |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Secondary diagnosis is present |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MFS |
|
59455-6 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
Dx; Finding; Findings; Morse Fall Score; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Secondary Dx; Secondary dx present; Survey; SURVEY.MFS |
2.68 |
2.32 |
|
|
|
|
|
|
|
|
|
|
Release 2.68: METHOD_TYP: The Method was removed because this is a generic term that can be used across contexts.; ANSWER_LIST_TYPE: Answer List Type was changed from Normative to Example because the Method was removed.; COMPONENT: Component was updated to be more specific to distinguish it from 81885-6 |
0 |
59456-4 |
Ambulatory aid |
Find |
^Patient |
Pt |
Ord |
Morse Fall Scale |
|
ACTIVE |
Ambulatory aid [Morse Fall Scale] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MFS |
|
59456-4 |
|
Morse Fall Scale |
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; MFS; Morse Fall Score; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MFS |
2.44 |
2.32 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59457-2 |
Intravenous apparatus |
Find |
^Patient |
Pt |
Ord |
Morse Fall Scale |
|
ACTIVE |
Intravenous apparatus [Morse Fall Scale] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MFS |
|
59457-2 |
|
Morse Fall Scale |
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; MFS; Morse Fall Score; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MFS |
2.44 |
2.32 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59458-0 |
Gait |
Find |
^Patient |
Pt |
Ord |
Morse Fall Scale |
|
ACTIVE |
Gait [Morse Fall Scale] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MFS |
|
59458-0 |
|
Morse Fall Scale |
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; MFS; Morse Fall Score; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MFS |
2.44 |
2.32 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59459-8 |
Mental status |
Find |
^Patient |
Pt |
Ord |
Morse Fall Scale |
|
ACTIVE |
Mental status [Morse Fall Scale] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MFS |
|
59459-8 |
|
Morse Fall Scale |
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; MFS; Morse Fall Score; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MFS |
2.44 |
2.32 |
|
|
|
|
|
|
|
|
|
|
|
0 |
5946-9 |
Coagulation surface induced.factor substitution^immediately after addition of normal plasma |
Time |
PPP |
Pt |
Qn |
Coag |
|
ACTIVE |
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma |
|
MIN |
DefinitionDescription |
|
|
s |
|
|
|
|
|
|
COAG |
|
5946-9 |
|
Coag |
|
|
Observation |
|
|
|
0 |
aPTT imm NP PPP |
|
|
|
Y |
|
Activated partial thromboplastin time; aPTT; aPTT correction study; Clot; Clottable; Coag; Coagulation assay; Control; Fac; Fact; Hematology; Heme; imm NP; Immediatedly after 1:1 addition of; Little(A)PTT; Mixing studies; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube |
2.73 |
1.0d |
|
|
|
|
|
|
|
s |
|
|
|
0 |
59460-6 |
Fall risk total |
Score |
^Patient |
Pt |
Qn |
Morse Fall Scale |
|
ACTIVE |
Fall risk total [Morse Fall Scale] |
|
MIN |
DefinitionDescription |
|
|
# |
|
|
|
|
|
|
SURVEY.MFS |
|
59460-6 |
|
Morse Fall Scale |
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
MFS; Morse fall risk total; Morse Fall Score; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MFS; Tot; Totl |
2.73 |
2.32 |
|
|
|
|
|
|
|
{#} |
|
|
We made an administrative decision to define the total scores from various survey instruments as Quantitative rather than ordinal. There is no intention to change the existing meaning. Changed Component from "Morse Fall risk total" to "Fall risk total" to align existing terms and since the Method states what the fall risk score is based on (Morse Fall Scale). Also changed Scale from "Num" to "Score" since the result represents a score. |
0 |
59461-4 |
Fall risk level |
Find |
^Patient |
Pt |
Ord |
Morse Fall Scale |
|
ACTIVE |
Fall risk level [Morse Fall Scale] |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MFS |
|
59461-4 |
|
Morse Fall Scale |
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Levels; Levl; LV; LVL; MFS; Morse Fall Score; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MFS; VTE |
2.56 |
2.32 |
|
|
|
|
|
|
|
|
|
|
Changed Component from "Morse Fall risk level" to "Fall risk level" to align existing terms and since the Method states what the fall risk level is based on (Morse Fall Scale). |
0 |
59462-2 |
Clinical biochemist review |
Imp |
XXX |
Pt |
Nar |
|
|
ACTIVE |
Clinical biochemist review of results |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
59462-2 |
|
|
|
|
Observation |
|
|
|
0 |
Clinical biochemist review |
|
|
|
N |
|
Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Narrative; Other; Point in time; Random; Report; Spec; To be specified in another part of the message; Unspecified |
2.73 |
2.32 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59463-0 |
Lymphocytes/Leukocytes |
NFr |
Dial fld |
Pt |
Qn |
|
|
ACTIVE |
Lymphocytes/Leukocytes in Dialysis fluid |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
59463-0 |
|
|
|
|
Observation |
|
|
|
0 |
Lymphocytes NFr Dial fld |
|
|
|
N |
|
Diaf; Dialysate; Dialysis fluid; HEMATOLOGY/CELL COUNTS; Kidney; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Nephrology; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; WBC; WBCs; White blood cell; White blood cells |
2.79 |
2.32 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
59464-8 |
Microbiologist review |
Imp |
XXX |
Pt |
Nar |
|
|
ACTIVE |
Microbiologist review of results |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
59464-8 |
|
|
|
|
Observation |
|
|
|
0 |
Microbiologist review |
|
|
|
N |
|
Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Microbiology; Misc; Miscellaneous; Narrative; Other; Point in time; Random; Report; Spec; To be specified in another part of the message; Unspecified |
2.73 |
2.32 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59465-5 |
Pathologist review |
Imp |
XXX |
Pt |
Nar |
|
|
ACTIVE |
Pathologist review of results |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
59465-5 |
|
|
|
|
Both |
|
|
|
0 |
Path Rev |
|
|
|
N |
|
Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Narrative; Other; Path; Path Rev; PATHOLOGY; Point in time; Random; Report; Spec; To be specified in another part of the message; Unspecified |
2.73 |
2.32 |
|
|
|
|
|
|
|
|
|
|
Changed Order_Obs from 'Observation Only' to 'Both' to fit current order use cases. |
0 |
59466-3 |
Hematologist review |
Imp |
XXX |
Pt |
Nar |
|
|
ACTIVE |
Hematologist review of results |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
59466-3 |
|
|
|
|
Both |
|
|
|
0 |
Hematologist review |
|
|
|
N |
|
HEMATOLOGY/CELL COUNTS; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Narrative; Other; Point in time; Random; Report; Spec; To be specified in another part of the message; Unspecified |
2.73 |
2.32 |
|
|
|
|
|
|
|
|
|
|
Changed Order_Obs from 'Observation Only' to 'Both' to fit current order use cases. |
0 |
59467-1 |
Hemoglobin |
EntSCnc |
RBC |
Pt |
Qn |
|
|
ACTIVE |
MCHC [Entitic Moles/volume] in Red Blood Cells |
|
NAM |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
HEM/BC |
|
59467-1 |
|
|
|
|
Observation |
|
|
|
0 |
MCHC RBC-EntSCnc |
|
|
|
N |
|
Erythrocytes; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles |
2.79 |
2.32 |
|
|
|
|
|
|
|
mmol/L |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: Precoordination of the component with Property: mean concentration; the decision was to post coordinate and separate component and property; Previous Releases: Changed Short name 'Erythrocyte mean corpuscular hemoglobin concentration' to 'MCHC' for succinctness. |
0 |